Earnings Review
Dr Reddy's consol PAT up 1.85% YoY at INR 14.18 bln, but misses Street view
This story was originally published at 17:10 IST on 23 July 2025
Register to read our real-time news.Informist, Wednesday, Jul. 23, 2025
MUMBAI - Pharmaceuticals major Dr. Reddy's Laboratories Ltd. posted a consolidated net profit of INR 14.18 billion in the June quarter, up 1.85% on year. It missed the Street expectations of INR 15.48 billion for consolidated net profit. Its consolidated revenue for the reporting quarter rose 11.4% on year to INR 85.72 billion. The company declared its Apr-Jun results after market hours Wednesday.
* Dr Reddy's Apr-Jun consol net profit INR 14.18 bln
* Analysts saw Dr Reddy's Apr-Jun consol net profit at INR 15.48 bln
* Dr Reddy's Apr-Jun consol net profit INR 14.18 bln vs INR 13.92 bln yr ago
* Dr Reddy's Apr-Jun consol revenue INR 85.72 bln vs INR 76.96 bln year ago
* Dr Reddy's Apr-Jun consol EBITDA margin 26.7% vs 28.2% year ago
* Dr Reddy's Apr-Jun consol EBITDA INR 22.78 bln vs INR 21.60 bln year ago
* Dr Reddy's Apr-Jun consol R&D expenses INR 6.24 bln, up 1% on year
To read more please subscribe
Share this Story:
